Results: 3

1.
Figure 1

Figure 1. From: CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer.

Distribution of specimens with respect to CD1a positivity at the time of diagnosis.

F Cappello, et al. Br J Cancer. 2005 March 14;92(5):888-890.
2.
Figure 2

Figure 2. From: CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer.

Diagrams of follow-up analysis for the group of patients (n=166) diagnosed for BM (BMGT). As shown, 80.7% of lesions (n=134) were confirmed as BMGT, 13.9% (n=23) developed Dy, while 5.4% (n=9) developed Ca. Lesions of the group originally classified as CD1a− were significantly more prone to evolve to Dy (P<0.0002) or Ca (P<0.0005) with respect to the CD1a+ group.

F Cappello, et al. Br J Cancer. 2005 March 14;92(5):888-890.
3.
Figure 3

Figure 3. From: CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer.

Panel of immunohistochemistry microphotographs showing a biopsy for BM (A) with positive CD1a dendritic elements between epithelial cells (B), as well as positive epithelial cells at the level of metaplastic glands (C). By contrast, CD1a was absent in dysplastic (D) and neoplastic (E) glands as well as in normal gastric mucosa (F).

F Cappello, et al. Br J Cancer. 2005 March 14;92(5):888-890.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk